Brokerage Radar: BofA cuts Hero MotoCorp's target price; analysts bullish on HAL, M&M

Morgan Stanley On M&M
Overweight Call, Target `3,304/Sh
Co Has Shown Good Success In Its Past Launches
Found Thar Five-Door Package Also Impressive
Thar Three-Door Sales Stand At 5,900 Units/Month (Last Six Months' Average)
Expect Three- And Five-Door Variants To Collectively Clock 8,000-9,000 Unit Sales/Month
Maintain That M&M Will Be Fastest Growing PV Company
See A Strong Jump In Sales In Coming Months, Driven By Festive Demand

Hindustan Aeronautics

Jefferies On HAL Buy Call, Target `5,725/Sh
Q1 Revenue Was 3% Above Expectations
EBITDA Was Lower As Margins Contracted 440 bps To 22.8%
Depreciation Was 27% Lower YoY And Contributed To The Profit Beat
Believe Strong Order Book Gives Confidence Of Double-Digit Growth For 3-5 Yrs
Volatile Margin Should Pick-Up In H2 With Revenue Delivery

UBS On HAL Buy Call, Target `5,700/Sh
Q1 Operationally In Line; On Course For Robust Ordering Momentum
Expect HNAL To Receive Orders Of `1 Lk Cr In FY25
LCH Prachand, 240AL31 Engines & SU30 Upgrades Being Major Ones
Expect `2 Lk Cr To Be Awarded Over The FY25-26 Period

CLSA On HAL Outperform Call, Target `4,731/Sh
Pipeline Intact & Q1 Weak Large Engine Orders Pushed To Q2 & Rest To H2FY25
1QFY25 EBITDA Down 6% But PAT Up 14% YoY
Orders Slowed On A Delay In Russia-Linked Programs To 2QFY25

HSBC On Ola Electric Mobility Initiate Buy, Target `140/Sh
Despite Conservative View On EV Penetration In India Along With Other Uncertainties
Believe Ola Is Worth Investing In Given Sustained Regulatory Support
Ola’s Has The Ability To Reduce Costs, With +Ve Risk-Reward In Its Battery Venture
Slower Penetration Of e2-wheelers & Battery Plant Issues Are Key Downside Risks

Jefferies On GMR Infra Buy Call, Target Raised To `106/Sh
Q1 EBITDA Ahead Of Est On 8% Growth In Pax Traffic
Q1 Saw Growth In Non-Aero And Subsidiary Rev
Co Recently Announced Completion Of Simplification Of Holding Structure
Co Recently Announced Re-Opening Of T1 At DIAL (New Terminal)
New Tariff At DIAL Is Expected By Q4FY25
Co Is Focussed On Growing Non-Aero Biz
With More Capacity, Non-aero Rev/Pax May See A Healthy Jump From Q3/4QFY25

Apollo Hospitals HSBC On Apollo Hosp Buy Call, Target `7,215/Sh
Q1 Hospitals (HCS) Revenue Growth Led By 11% Inpatient Volume Growth
Other Segments Also Grew Mid-Teens
HCS Outlook Intact For 24/7 To Achieve Cost Breakeven In 6-7 Quarters
HCS Gross Merchandise Value (GMV) Picking Up
Launch Of Insurance Service Via 24/7 Platform Will Be Key

MS On Apollo Hospitals Overweight Call, Target `7,110/Sh
Cons EBITDA After 24x7 Cost Was `670 Cr, In-Line With Est & Consensus Est
Net Profit (After Minority Interests) Came In At `310 Cr

Max Financial Services

Nomura On Max Fin Downgrade To Neutral, Target `1,130/Sh
VNB Growth To Lag Peers, Potential Upside Looks Limited
Mgmt Expects New SV Regulations To Impact VNB Margin By 100-200 bps
Believe Max Life Will Have To Deliver Much Higher VNB Growth To Meet Its Guidance

Jefferies On Max Fin Buy Call, Target `1,270/Sh
Saw Weaker VNB Growth Of 3% YoY Despite 31% Rise In Premium
Weaker Mix Dragged Margins
Co Is Benefiting From Ramp-Up Of E-Com, Agency And Integration With Axis
Encouraged To See Mgt Indicate Limited Impact Of New SV Norms On Margin
Limited Impact Of SV Norms This Will Aid Mid-Teen Growth In VNB Over FY26-27

Nomura On IPCA Labs Buy Call, Target Raised To `1,502/Sh
Earnings Ahead Of Estimates; International Revenues Weak
Low Costs & A Sustained EBITDA Recovery At Unichem Were Key Positives
International Sales Were Impacted By Technical & Supply Chain Issues
But, These Issues Should Be Addressed In Due Course
For FY25 Mgmt Now Expects Standalone Rev Growth A 9% (Previously 10.5-11%)
Projects EBITDA Margin At 18.5-19.5% (Previously 18.0-18.5%)
Forecast A 25% Earnings CAGR Over FY25-27
Raise FY25F/26 EPS By 6%/3% On Likely Declined Costs

HSBC On Rainbow Hospitals Downgrade To Neutral, Target Cut To `1,290 From `1,500/Sh
Revenue Was In-Line In Q1; Costs For New Units Lowered EBITDA Margin
Expect Rangebound EBITDA Margin At 30-31%
Growth Drivers Priced In, In Our View

JPMorgan On DLF Overweight Call, Target Raised To `1,000/Sh
Believe Co Will Surpass A Coveted $1bn Operating Cash Flow At Group Level In FY25
Co Riding A Strong Sales Cycle & Compounding Of Free Cash At Its Rental Business
This Opens Up Significant Strategic Flexibility At Group Level On Acquisitions
See Upside To Pre-Sales, Margin & Cash Flow In FY25

Jefferies On Nazara Downgrade To Underperform Call, Target `720/Sh
Q1 Results Missed Estimates Due To Continued Weakness In Most Segments
Unclear Success Rates On Recent Acquisitions, Adds To Execution Risks
Raise FY25/27 Revenue/EBITDA Ests By 24-36%
Cut Earnings By 6-29% To Factor Acquisitions

Disclaimer: The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not those of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.